Effect of direct albumin binding to sphingosylphosphorylcholine in Jurkat T cells

Prostaglandins and Other Lipid Mediators

Volumn 84, Issue 3-4, 2007, Pages 174-183

  Han, Mijin ^a   Kim, Yu Lee ^a   Sacket, Santosh J ^a   Kim, Kyeok ^a   Kim, Hyo Lim ^a   Jo, Ji Yeong ^a   Ha, Nam Chul ^a   Im, Dong Soon ^a  

^a Pusan National University   (South Korea)

Author keywords

Albumin; Cytotoxicity; Lipid; Serum; Sphingosylphosphorylcholine; Viability

Indexed keywords

ALBUMIN; CALCIUM; LYSOPHOSPHOLIPID; MATRIX METALLOPROTEINASE; REACTIVE OXYGEN METABOLITE; SPHINGOSYLPHOSPHORYLCHOLINE;

ANALYTIC METHOD; ARTICLE; CELL PROTECTION; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE;

ANIMALS; CALCIUM; CALORIMETRY; CATTLE; CELL SURVIVAL; HUMANS; JURKAT CELLS; MEMBRANE POTENTIAL, MITOCHONDRIAL; PHOSPHORYLCHOLINE; REACTIVE OXYGEN SPECIES; SERUM ALBUMIN, BOVINE; SPHINGOSINE; T-LYMPHOCYTES;

EID: 35649005362     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2007.08.003     Document Type: Article

References (55)

1. Maceyka M., Payne S.G., Milstien S., and Spiegel S. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim Biophys Acta 1585 2-3 (2002) 193-201
2. Spiegel S., and Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 4 5 (2003) 397-407
3. Meyer zu Heringdorf D., Himmel H.M., and Jakobs K.H. Sphingosylphosphorylcholine-biological functions and mechanisms of action. Biochim Biophys Acta 1582 1-3 (2002) 178-189
4. Liliom K., Sun G., Bunemann M., et al. Sphingosylphosphocholine is a naturally occurring lipid mediator in blood plasma: a possible role in regulating cardiac function via sphingolipid receptors. Biochem J 355 Pt. 1 (2001) 189-197
5. Nofer J.R., Fobker M., Hobbel G., et al. Activation of phosphatidylinositol-specific phospholipase C by HDL-associated lysosphingolipid. Involvement in mitogenesis but not in cholesterol efflux. Biochemistry 39 49 (2000) 15199-15207
6. Nofer J.R., Levkau B., Wolinska I., et al. Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids. J Biol Chem 276 37 (2001) 34480-34485
7. Rodriguez-Lafrasse C., and Vanier M.T. Sphingosylphosphorylcholine in Niemann-Pick disease brain: accumulation in type A but not in type B. Neurochem Res 24 2 (1999) 199-205
8. Xiao Y.J., Schwartz B., Washington M., et al. Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: comparison of the lysophospholipid contents in malignant vs. nonmalignant ascitic fluids. Anal Biochem 290 2 (2001) 302-313
9. Hla T., Lee M.J., Ancellin N., Paik J.H., and Kluk M.J. Lysophospholipids-receptor revelations. Science 294 5548 (2001) 1875-1878
10. Im D.S. Discovery of new G protein-coupled receptors for lipid mediators. J Lipid Res 45 3 (2004) 410-418
11. Lynch K.R., and Im D.S. Life on the edg. Trends Pharmacol Sci 20 12 (1999) 473-475
12. Lee M.J., Van Brocklyn J.R., Thangada S., et al. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 279 5356 (1998) 1552-1555
13. Okamoto H., Takuwa N., Yatomi Y., Gonda K., Shigematsu H., and Takuwa Y. EDG3 is a functional receptor specific for sphingosine 1-phosphate and sphingosylphosphorylcholine with signaling characteristics distinct from EDG1 and AGR16. Biochem Biophys Res Commun 260 1 (1999) 203-208
14. Gonda K., Okamoto H., Takuwa N., et al. The novel sphingosine 1-phosphate receptor AGR16 is coupled via pertussis toxin-sensitive and -insensitive G-proteins to multiple signalling pathways. Biochem J 337 Pt. 1 (1999) 67-75
15. 2+ signaling pathway. Biochem Biophys Res Commun 268 2 (2000) 583-589
16. Im D.S., Heise C.E., Ancellin N., et al. Characterization of a novel sphingosine 1-phosphate receptor, Edg-8. J Biol Chem 275 19 (2000) 14281-14286
17. Van Brocklyn J.R., Graler M.H., Bernhardt G., Hobson J.P., Lipp M., and Spiegel S. Sphingosine-1-phosphate is a ligand for the G protein-coupled receptor EDG-6. Blood 95 8 (2000) 2624-2629
18. Desai N.N., and Spiegel S. Sphingosylphosphorylcholine is a remarkably potent mitogen for a variety of cell lines. Biochem Biophys Res Commun 181 1 (1991) 361-366
19. Desai N.N., Carlson R.O., Mattie M.E., et al. Signaling pathways for sphingosylphosphorylcholine-mediated mitogenesis in Swiss 3T3 fibroblasts. J Cell Biol 121 6 (1993) 1385-1395
20. 2+ signaling induced by sphingosylphosphorylcholine and sphingosine 1-phosphate via distinct mechanisms in rat glomerular mesangial cells. Kidney Int 54 5 (1998) 1470-1483
21. 2+ mobilization by sphingosylphosphorylcholine and galactosylsphingosine in HL60 leukemia cells. Implications of GTP-binding protein-coupled receptors for lysosphingolipids. J Biol Chem 270 44 (1995) 26332-26340
22. 2+ entry. Cardiovasc Res 68 1 (2005) 56-64
23. 2+-sensitization of vascular smooth muscle contraction: possible involvement of rho-kinase. FEBS Lett 482 1-2 (2000) 85-90
24. i protein-coupled receptor for sphingosylphosphorylcholine in human leukemia HL-60 cells and human neutrophils. Mol Pharmacol 49 6 (1996) 956-961
25. Sun L., Xu L., Henry F.A., Spiegel S., and Nielsen T.B. A new wound healing agent-sphingosylphosphorylcholine. J Invest Dermatol 106 2 (1996) 232-237
26. Wakita H., Matsushita K., Nishimura K., Tokura Y., Furukawa F., and Takigawa M. Sphingosylphosphorylcholine stimulates proliferation and upregulates cell surface-associated plasminogen activator activity in cultured human keratinocytes. J Invest Dermatol 110 3 (1998) 253-258
27. Seufferlein T., and Rozengurt E. Sphingosylphosphorylcholine activation of mitogen-activated protein kinase in Swiss 3T3 cells requires protein kinase C and a pertussis toxin-sensitive G protein. J Biol Chem 270 41 (1995) 24334-24342
28. 2+-dependent pathway. Am J Physiol 275 5 Pt. 1 (1998) C1255-C1263
29. Sekiguchi K., Yokoyama T., Kurabayashi M., Okajima F., and Nagai R. Sphingosylphosphorylcholine induces a hypertrophic growth response through the mitogen-activated protein kinase signaling cascade in rat neonatal cardiac myocytes. Circ Res 85 11 (1999) 1000-1008
30. Jeon E.S., Kang Y.J., Song H.Y., et al. Role of MEK-ERK pathway in sphingosylphosphorylcholine-induced cell death in human adipose tissue-derived mesenchymal stem cells. Biochim Biophys Acta 1734 1 (2005) 25-33
31. Seufferlein T., and Rozengurt E. Sphingosylphosphorylcholine rapidly induces tyrosine phosphorylation of p125FAK and paxillin, rearrangement of the actin cytoskeleton and focal contact assembly. Requirement of p21rho in the signaling pathway. J Biol Chem 270 41 (1995) 24343-24351
32. 2+ current by lysosphingolipids in RINm5F insulinoma cells. Mol Pharmacol 53 5 (1998) 862-869
33. Uhlenbrock K., Gassenhuber H., and Kostenis E. Sphingosine 1-phosphate is a ligand of the human gpr3, gpr6 and gpr12 family of constitutively active G protein-coupled receptors. Cell Signal 14 11 (2002) 941-953
34. Ignatov A., Lintzel J., Hermans-Borgmeyer I., et al. Role of the G-protein-coupled receptor GPR12 as high-affinity receptor for sphingosylphosphorylcholine and its expression and function in brain development. J Neurosci 23 3 (2003) 907-914
35. Im D.S. Two ligands for a GPCR, proton vs. lysolipid. Acta Pharmacol Sin 26 12 (2005) 1435-1441
36. Meyer zu Heringdorf D., and Jakobs K.H. Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism. Biochim Biophys Acta 1768 4 (2007) 923-940
37. Xu Y., Zhu K., Hong G., et al. Retraction. Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1. Nat Cell Biol 8 3 (2007) 299
38. Zhu K., Baudhuin L.M., Hong G., et al. Retraction. Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. J Biol Chem 280 52 (2005) 43280
39. Konikova E., Babusikova O., Kusenda J., and Glasova M. Detection of cytoplasmic and surface membrane markers in cells of some human hematopoietic cell lines. Neoplasma 39 6 (1992) 337-342
40. Im Y.J., Lee Y.K., Chung H.Y., and Im D.S. Multiple actions of lysophosphatidylcholine in human Jurkat T cells. Acta Pharmacol Sin 27 6 (2006) 700-707
41. Kim Y.L., Im Y.J., Ha N.C., and Im D.S. Albumin inhibits cytotoxic activity of lysophosphatidylcholine by direct binding. Prostaglandins Other Lipid Mediat 83 1-2 (2007) 130-138
42. Quinlan G.J., Martin G.S., and Evans T.W. Albumin: biochemical properties and therapeutic potential. Hepatology 41 6 (2005) 1211-1219
43. Schreck R., Rieber P., and Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10 8 (1991) 2247-2258
44. Larsson R., and Cerutti P. Oxidants induce phosphorylation of ribosomal protein S6. J Biol Chem 263 33 (1988) 17452-17458
45. Finkel T. Redox-dependent signal transduction. FEBS Lett 476 1-2 (2000) 52-54
46. Lieber M.R. Warner-Lambert/Parke-Davis Award Lecture. Pathological and physiological double-strand breaks: roles in cancer, aging, and the immune system. Am J Pathol 153 5 (1998) 1323-1332
47. Dobmeyer T.S., Findhammer S., Dobmeyer J.M., et al. Ex vivo induction of apoptosis in lymphocytes is mediated by oxidative stress: role for lymphocyte loss in HIV infection. Free Radic Biol Med 22 5 (1997) 775-785
48. Dandona P., Thusu K., Cook S., et al. Oxidative damage to DNA in diabetes mellitus. Lancet 347 8999 (1996) 444-445
49. McAllister-Sistilli C.G., Caggiula A.R., Knopf S., Rose C.A., Miller A.L., and Donny E.C. The effects of nicotine on the immune system. Psychoneuroendocrinology 23 2 (1998) 175-187
50. Frenkel K., Khasak D., Karkoszka J., Shupack J., and Stiller M. Enhanced antibody titers to an oxidized DNA base in inflammatory and neoplastic diseases. Exp Dermatol 1 5 (1992) 242-247
51. 2+ signaling and control of growth and proliferation. Biol Cell 96 1 (2004) 55-68
52. Mochizuki M., Zigler Jr. J.S., Russell P., and Gery I. Serum proteins neutralize the toxic effect of lysophosphatidyl choline. Curr Eye Res 2 9 (1982) 621-624
53. Soga T., Ohishi T., Matsui T., et al. Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor. Biochem Biophys Res Commun 326 4 (2005) 744-751
54. 2 induces neurite outgrowth in PC12 cells through lysophosphatidylcholine generation and activation of G2A receptor. J Biol Chem 280 30 (2005) 28044-28052
55. Jeon E.S., Kang Y.J., Song H.Y., et al. Sphingosylphosphorylcholine generates reactive oxygen species through calcium-, protein kinase Cδ- and phospholipase D-dependent pathways. Cell Signal 17 6 (2005) 777-787